Oral L-arginine improves endothelial dysfunction in patients with essential hypertension

被引:99
|
作者
Lekakis, JP [1 ]
Papathanassiou, S [1 ]
Papaioannou, TG [1 ]
Papamichael, CM [1 ]
Zakopoulos, N [1 ]
Kotsis, V [1 ]
Dagre, AG [1 ]
Stamatelopoulos, K [1 ]
Protogerou, A [1 ]
Stamatelopoulos, SF [1 ]
机构
[1] Univ Athens, Dept Clin Therapeut, Alexandra Hosp, Athens, Greece
关键词
L-arginine; endothelium-dependent vasodilation; hypertension;
D O I
10.1016/S0167-5273(02)00413-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: L-Arginine is a nitric oxide precursor, which augments endothelium-dependent vasodilatation in hypercholesterolemic humans and animals. Endothelium-dependent vasodilation is attenuated in patients with hypertension; however the effects of oral L-arginine on endothelial function of the conduit arteries in patients with essential hypertension have not previously been investigated. Methods: In a prospective randomized double blind trial, 35 patients with essential hypertension received either 6 g L-arginine (18 subjects) or placebo (17 subjects). Patients were examined for flow-mediated endothelium-dependent dilatation of the brachial artery before and 1.5 h after administration of L-arginine or placebo. At the end of the protocol the nitrate-induced, endothelium-independent vasodilatation was evaluated. Results: Two groups of L-arginine and placebo were similar regarding age, sex, blood lipids, smoking, diabetes, coronary artery disease, body mass index, intima-media thickness of the common carotid artery, clinics blood pressure and baseline brachial artery parameters. Administration of L-arginine or placebo did not change significantly heart rate, blood pressure, baseline diameter, blood flow or reactive hyperemia. L-Arginine resulted in a significant improvement of flow-mediated dilatation (1.7 +/- 3.4 vs. 5.9 +/- 5.4%, P = 0.008) while placebo did not significantly change this parameter (3.0 +/- 2.7 vs. 3.1 +/- 2.2%, P = ns). The effect of L-arginine on flow-mediated dilatation was significantly different from the effect of placebo (P = 0.05). L-Arginine did not significantly influence nitrate-induced dilatation (16 +/- 6.9 vs. 17.7 +/- 6.7%, P = ns). Conclusions: Oral administration of L-arginine acutely improves endothelium-dependent, flow-mediated dilatation of the brachial artery in patients with essential hypertension. The long-term effects of L-arginine in these patients require further investigation. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 50 条
  • [1] Oral L-arginine improves endothelial dysfunction in patients with essential hypertension
    Lekakis, J
    Papathanasiou, S
    Papamichael, C
    Zakopoulos, N
    Kotsis, V
    Dagre, A
    Papaioannou, T
    Stamatelopoulos, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 260A - 260A
  • [2] Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension
    Perticone, F
    Sciacqua, A
    Maio, R
    Perticone, M
    Maas, R
    Boger, RH
    Tripepi, G
    Sesti, G
    Zoccali, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) : 518 - 523
  • [3] Oral L-arginine supplementation improves essential arterial hypertension
    Pagnotta, P
    Germano, G
    Grutter, G
    Leonardo, F
    Rosano, GMC
    Chierchia, SL
    CIRCULATION, 1997, 96 (08) : 3015 - 3015
  • [4] L-arginine improves erectile dysfunction in patients
    von Hein, C. P.
    Stichtenoth, D. O.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 96 - 97
  • [5] Oral L-arginine therapy improves endothelial dysfunction in patients with recurrent chest pain and normal coronary arteries
    Shechter, M.
    Guetta, V.
    Feinberg, M. S.
    Agranat, O.
    Freimark, D.
    Arad, M.
    Digegni, E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 708 - 709
  • [6] Oral L-arginine improves exercise tolerance and flow related endothelial dysfunction in microvascular angina
    Bellamy, MF
    Goodfellow, J
    Tweddel, AC
    Brownlee, M
    Gorman, ST
    Ellis, GR
    MacCarthy, PA
    Lewis, MJ
    Henderson, AH
    CIRCULATION, 1996, 94 (08) : 2478 - 2478
  • [7] Normalization of endothelial dysfunction by oral supplement of L-arginine in smokers
    Lin, CC
    Tsai, WC
    Chao, TH
    Chen, JH
    JOURNAL OF HYPERTENSION, 2003, 21 : S4 - S4
  • [8] Oral L-arginine therapy reverses hypertension and endothelial dysfunction in young cardiac transplant recipients
    Lim, S
    Mooradian, S
    Gomez, C
    Goldberg, C
    Crowley, DC
    Rocchini, AP
    Charpie, JR
    CIRCULATION, 2001, 104 (17) : 692 - 692
  • [9] L-arginine chlorination and endothelial dysfunction
    White, CR
    Zhang, CX
    Ma, WX
    FASEB JOURNAL, 2001, 15 (04): : A244 - A244
  • [10] Carvedilol improves endothelial dysfunction in patients with essential hypertension
    Watanabe, H
    Nakagawa, K
    Kakihana, M
    CIRCULATION, 1999, 100 (18) : 104 - 104